Zobrazeno 1 - 10 of 168 pro vyhledávání: '"E Manzin"'
2
Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse
Autor: G Moro, Antonio Durando, E. Manzin, Marco Massobrio, Maria Giuseppa Sarobba, Antonio Farris, Giorgio Bonazzi, Alfredo Berruti, Francesco Nuzzo, Michela Donadio, Federico Castiglione, A. de Matteis, Luigi Dogliotti, Alberto Bottini, Raffaella Bitossi, E. de Fabiani, Marco Tampellini, Gabriella Gorzegno, P. Arese
Publikováno v: Tumor Biology. 22:367-373
Data currently available are insufficient to demonstrate a real utility for CA 15-3 in the diagnosis, staging or surveillance of breast cancer patients following primary treatment. The aim of this study was to determine if there was a correlation bet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d1199ce3ac1df4abfa8319f80a0cf8
https://doi.org/10.1159/000050639
Zobrazit plný text záznamu
3
Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction
Autor: M. Bernasconi, A. Rossi, R. Poggi, E. Manzin, R. Brandolese
Publikováno v: Intensive Care Medicine. 16:108-114
To investigate the dose-response relationship and the time course of the effects of fenoterol (a selective β2-adrenergic agonist) on respiratory function in mechanically ventilated patients with acute respiratory failure due to exacerbation of chron
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7534dc220b4db8aa855f5a6ba3fbd7f4
https://doi.org/10.1007/bf02575304
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Multimodal management of stages III-IVa malignant thymoma
Autor: M Sacco, Giuliano Maggi, Caterina Casadio, E Manzin, Luigi Dogliotti, G L Sannazzari, Alfredo Berruti, C Loddo, Francesco Ardissone, Paola Sperone, Piero Borasio, M. Tessa, S. Bretti, Gabriella Gorzegno
Purpose: The optimal therapy for locally advanced malignant thymoma is controversial. We review our experience with a multimodal approach in 63 consecutive cases. Patients and methods: Forty-three patients had stage III and 20 stage IVa disease. Surg
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239c158edc4e6e4e368ceb137864e277
http://hdl.handle.net/11379/469207
Zobrazit plný text záznamu
6
Gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a phase II study
Autor: S, Bretti, E, Manzin, C, Loddo, A, Berruti, S, Bombaci, G, Vellani, A, Celano
Lung cancer is the leading cause of cancer death in men worldwide; most cases are not suitable for radical surgery at diagnosis and palliative treatment remains the primary goal of therapy. Cisplatin and gemcitabine are among the most active cytotoxi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2d6293bbdb79c9f19fbae5d63cd50650
http://hdl.handle.net/11379/469095
Zobrazit plný text záznamu
7
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
Autor: Alfredo Berruti, Federico Castiglione, Cesare Bumma, Maria Giuseppa Sarobba, S. Danese, Oscar Bertetto, Vito Lorusso, E. DeFabiani, Gabriella Gorzegno, G. Moro, Luigi Dogliotti, A. Bottini, E. Manzin, Michela Donadio
Publikováno v: Cancer chemotherapy and pharmacology. 47(5)
Paclitaxel is now included in second- and even first-line regimens in advanced breast cancer. The optimal dose and schedule of this drug, however, still remain a matter of investigation. A group of 57 consecutive patients with advanced breast cancer
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92b75795cb4ddb18cc2b09d848c037f3
https://pubmed.ncbi.nlm.nih.gov/11391853
Zobrazit plný text záznamu
8
Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study
Autor: Alfredo Berruti, S. Bretti, C Loddo, G. Ritorto, E. Manzin, A Celano
Platinum compounds and vinorelbine (VNB) are active in the treatment of non-small cell lung cancer (NSCLC), but moderate toxicity has been reported. The aims of the present study were to assess activity and tolerability of low dose carboplatin (CBDCA
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31a7f2ad0f12002d859db0a5f713d7ed
http://hdl.handle.net/11379/469187
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje